CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while ...

SPONSORED – The problems that cause a person to gain weight or not be able to lose weight are unique for each person. At Simply Health Integrated Medical, the goal is to help people get healthy first, ...

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading Into 2026NEWARK, DE, Jan. 09, 2026 (GLOBE NEWSWIRE) -- ...

Read detailed MedVI reviews to learn how GLP-1 medications like semaglutide & tirzepatide support appetite control & ...

In the face of skyrocketing costs, Virta sets new standard for employers and health plans aiming to address obesity and GLP-1 spending, with no financial risk The costs of GLP-1s for weight loss are ...

New research found GLP-1 users in the real world lose less weight compared to participants in clinical trials. Fact checked by Nick Blackmer Wegovy, Zepbound, and other glucagon-like peptide-1 (GLP-1) ...

As medical weight loss continues to evolve in 2026, the landscape of GLP-1 therapies has reached a pivotal moment with ...

Sprout Health Serves as Case Study for Provider Model Structure, Program Costs, and FDA-vs-Compounded Disclosure ...

Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...